News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
621,891 Results
Type
Article (60283)
Company Profile (52)
Press Release (561556)
Section
Business (172447)
Career Advice (2678)
Deals (32345)
Drug Delivery (75)
Drug Development (76370)
Employer Resources (147)
FDA (14690)
Job Trends (13786)
News (302569)
Policy (28799)
Tag
Academia (2863)
Africa (861)
Alabama (29)
Allergies (40)
Alliances (42572)
Alzheimer's disease (1048)
Antibody-drug conjugate (ADC) (38)
Approvals (14640)
Arizona (109)
Artificial intelligence (47)
Asia (36848)
Australia (6614)
Bankruptcy (280)
Best Places to Work (10417)
Biosimilars (51)
C2C Services and Suppliers (67181)
California (740)
Canada (571)
Cancer (172)
Career advice (2263)
CAR-T (37)
Cell therapy (72)
China (40)
Clinical research (59229)
Collaboration (53)
Colorado (35)
COVID-19 (2439)
Cystic fibrosis (68)
Diabetes (27)
Diagnostics (5682)
Diversity, equity & inclusion (39)
Drug pricing (48)
Earnings (56668)
Employer resources (126)
Europe (85544)
Events (89638)
Executive appointments (26)
FDA (14734)
Florida (101)
Funding (30)
Gene therapy (48)
GLP-1 (454)
Government (4331)
Healthcare (17950)
Hotbed/Location (410642)
Idaho (54)
Illinois (207)
Indiana (95)
Infectious disease (2448)
Inflammatory bowel disease (84)
Interviews (518)
IPO (14436)
Job creations (3398)
Job search strategy (1927)
Kansas (83)
Layoffs (397)
Legal (6345)
Liver cancer (50)
Lung cancer (33)
Maine (46)
Management (47)
Manufacturing (36)
Maryland (227)
Massachusetts (364)
Medical device (12244)
Medtech (12247)
Mergers & acquisitions (17677)
Metabolic disorders (139)
Neuroscience (1119)
New Jersey (57)
New York (75)
NextGen Class of 2024 (6335)
Non-profit (4278)
North Carolina (161)
Obesity (92)
Opinion (182)
Parkinson's disease (29)
Patents (31)
Peanut (36)
Pennsylvania (47)
People (57691)
Phase I (18532)
Phase II (26144)
Phase III (19151)
Policy (33)
Postmarket research (2462)
Preclinical (7929)
Rare diseases (88)
Real estate (5952)
Recruiting (59)
Regulatory (18840)
Research institute (2374)
Resumes & cover letters (398)
South America (1167)
Startups (3313)
Texas (81)
United States (2710)
Vaccines (405)
Washington State (98)
Weight loss (88)
Date
Today (45)
Last 7 days (445)
Last 30 days (1720)
Last 365 days (34695)
2024 (19503)
2023 (36346)
2022 (46633)
2021 (51574)
2020 (50730)
2019 (44798)
2018 (34067)
2017 (30742)
2016 (30078)
2015 (35451)
2014 (28408)
2013 (24978)
2012 (26226)
2011 (26465)
2010 (24945)
621,891 Results for "university of barcelona".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis (FAP) to be Presented at Prestigious Biennial InSIGHT 2024 Meeting in Barcelona
Biodexa Pharmaceuticals PLC announces that 12 month data of a Phase 2 clinical trial of eRapa in Familial Adenomatous Polyposis are to be presented at the prestigious biennial InSIGHT 2024 meeting in Barcelona, Spain on June 22, 2024.
June 10, 2024
·
6 min read
Business
IMIDomics Establishes a License and Collaboration Partnership with the University of Barcelona to Advance Treatments for IMIDs
IMIDomics Inc. today announced a strategic license and collaboration agreement with the University of Barcelona (UB).
October 11, 2023
·
3 min read
BioNxt Solutions Reports on Barcelona CPHI Conference
BioNxt Solutions Inc. is pleased to report on a successful CPHI pharma conference in Barcelona, Spain, recently attended by BioNxt’s European team.
November 6, 2023
·
3 min read
ILiAD Biotechnologies Announces Presentation at the 2023 World Vaccine Congress in Barcelona
ILiAD Biotechnologies, LLC (ILiAD), a vaccine company utilizing its B-Tech technology to develop novel vaccines against infectious diseases, today announced Chief Medical Officer Stephanie Noviello, MD, MPH, will present data on its pertussis vaccine, BPZE1, at the World Vaccine Congress Europe in Barcelona, Spain (October 17 – 19, 2023).
October 18, 2023
·
4 min read
Biotech Bay
Pharmatech Associates Showcases Strategic Program Development for Drug Sponsors and Innovators at CPHI Barcelona 2023
This week at CPHI Barcelona, Pharmatech Associates will showcase its expertise and capabilities that help global pharmaceutical and emerging biotech companies accelerate their innovation and speed delivery of breakthrough medicines and therapies to patients.
October 24, 2023
·
5 min read
Scinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) today announced that it will be showcasing its CDMO services at CPHI Barcelona, one of the international pharmaceutical industry’s premier trade shows, taking place October 24 to 26.
October 4, 2023
·
3 min read
Business
Theriva™ Biologics and Sant Joan de Déu-Barcelona Children’s Hospital Advance Strategic Collaboration to Explore the Combination of VCN-01 with Topoisomerase Inhibitors to Treat Cancer
Theriva™ Biologics and Sant Joan de Déu-Barcelona Children’s Hospital announced that Theriva has executed an exclusive worldwide option to negotiate an exclusive license certain SJD intellectual property rights related to the use of VCN-01 in combination with topoisomerase I inhibitor chemotherapies for the treatment of cancer.
November 2, 2023
·
9 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
The University of Barcelona and Poietis announce their partnership to set-up a GMP-compliant bioprinting facility in the Production and Validation Center for Advanced Therapies of the University (CREATIO)
With the acquisition of the NGB (Next-Generation Bioprinting) high-resolution robotic bioprinting platform developed by Poietis the University of Barcelona becomes a reference in Tissue Engineering
September 26, 2022
·
5 min read
1 of 62,190
Next
